Back to School: How biopharma can reboot drug development. Access exclusive analysis here

Tengion raises $33.6 million

Tengion Inc. (OTCQB:TNGN) raised $33.6 million on Monday, including $15 million in cash from existing investor Celgene

Read the full 172 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE